E7 T-Cell Receptor (TCR)

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Oropharyngeal NeoplasmsPapillomavirus InfectionsUterine Cervical Neoplasms

Early Phase 1

E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer

TerminatedNCT04476251

National Cancer Institute (NCI)Uterine Cervical Neoplasms

Start: 2021-01-14End: 2021-09-15Updated: 2021-12-15

Phase 2

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

TerminatedNCT04015336

National Cancer Institute (NCI)Oropharyngeal Neoplasms, Papillomavirus Infections

Start: 2020-07-06End: 2020-07-15Updated: 2022-02-24